Authors: Saramaki, OR Savinainen, KJ Nupponen, NN Bratt, O Visakorpi, T

Citation: Or. Saramaki et al., Amplification of hypoxia-inducible factor 1 alpha gene in prostate cancer, CANC GENET, 128(1), 2001, pp. 31-34

Authors: Saramaki, O Willi, N Bratt, O Gasser, TC Koivisto, P Nupponen, NN Bubendorf, L Visakorpi, T

Citation: O. Saramaki et al., Amplification of EIF3S3 gene is associated with advanced stage in prostatecancer, AM J PATH, 159(6), 2001, pp. 2089-2094

Authors: Bratt, O

Citation: O. Bratt, Hereditary prostate cancer, BJU INT, 85(5), 2000, pp. 588-598

Authors: Bratt, O Damber, JE Emanuelsson, M Kristoffersson, U Lundgren, R Olsson, H Gronberg, H

Citation: O. Bratt et al., Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer, EUR J CANC, 36(2), 2000, pp. 235-241

Authors: Bratt, O Kristoffersson, U Lundgren, R Olsson, H

Citation: O. Bratt et al., Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study, EUR J CANC, 35(2), 1999, pp. 272-277

Authors: Bratt, O Borg, A Kristoffersson, U Lundgren, R Zhang, QX Olsson, H

Citation: O. Bratt et al., CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk, BR J CANC, 81(4), 1999, pp. 672-676